SCHEMBL2968880

SCHEMBL2968880

CCOc1cccc(C)c1C1CC1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.43
GLA P06280 1/20 0.43
FFAR1 O14842 4/20 0.41
FFAR4 Q5NUL3 1/20 0.39
MAPT P10636 2/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
POLB P06746 2/20 0.38
KMT2A Q03164 2/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2960964 0.85 FFAR1 (0.43) FFAR1ALDH1A1HPGDHCRTR1HCRTR2
SCHEMBL27363023 0.83 FFAR1 (0.50) FFAR1ALDH1A1HPGDPOLBRAB9A
SCHEMBL1208094 0.79 HTR2C (0.55) L3MBTL1GLAFFAR1FFAR4MAPT
SCHEMBL2973921 0.79 PTGER4 (0.47) FFAR1POLBKMT2ARAB9ATDP1
SCHEMBL2961356 0.74 TP53 (0.46) GLAALDH1A1KMT2ATSHRKDM4E
SCHEMBL2957111 0.73 PTGDR2 (0.47) FFAR1FFAR4MAPTALDH1A1POLB
SCHEMBL6903831 0.73 FFAR1 (0.42) FFAR1FFAR4CYP2C8CYP2C9HTR2A
SCHEMBL6907447 0.73 FFAR4 (0.41) FFAR4POLBHTR2AHTR2CHTR2B
SCHEMBL6901277 0.73 FFAR1 (0.42) FFAR1FFAR4CYP2C8CYP2C9HTR2A
SCHEMBL6901272 0.73 FFAR1 (0.42) FFAR1FFAR4CYP2C8CYP2C9HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763728-B2 Tetrahydropyridothiophenes 4SC AG (DE) 2010-07-27 US disclosed
US-20090257977-A1 NOVEL TETRAHYDROPYRIDOTHIOPHENES PEKARI KLAUS 2009-10-15 US disclosed
US-20080260749-A1 Novel Tetrahydropyridothiophenes NYCOMED GMBH (DE) 2008-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090257977-A1 NOVEL TETRAHYDROPYRIDOTHIOPHENES BAX, BCL2, CCAR2 L3MBTL1 2312/4885GLA 3335/4885FFAR1 3410/4885
US-20080260749-A1 Novel Tetrahydropyridothiophenes BAX, BCL2, CCAR2 L3MBTL1 2416/4885GLA 3261/4885FFAR1 3294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.